Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer

Nature Reviews Microbiology

Volumn 15, Issue 2, 2017, Pages 109-128

  Gagnaire, Aurélie ^a   Nadel, Bertrand ^a   Raoult, Didier ^b   Neefjes, Jacques ^c   Gorvel, Jean Pierre ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL TOXIN; BETA CATENIN; COLIBACTIN; CYTOLETHAL DISTENDING TOXIN; EXOENZYME S; FRAGILYSIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; BACTERIAL TRANSMISSION; BACTEROIDES FRAGILIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GALLBLADDER CARCINOMA; HELICOBACTER PYLORI; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALIGNANT NEOPLASM; MICROFLORA; NEISSERIA GONORRHOEAE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHI; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; WNT SIGNALING PATHWAY; GENETICS; HELICOBACTER INFECTION; METABOLISM; MICROBIOLOGY; NEOPLASM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

BACTERIAL TOXINS; CARCINOGENESIS; DNA DAMAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS;

EID: 85008319428     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.171     Document Type: Review

References (210)

1. Ferlay, J., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int. J. Cancer 136, E359-E386 (2015
2. Nagy, R., Sweet, K., & Eng, C. Highly penetrant hereditary cancer syndromes. Oncogene 23, 6445-6470 (2004
3. de Martel, C., et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13, 607-615 (2012
4. Peek, R. M., & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28-37 (2002
5. Chaturvedi A. K., et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol. Biomarkers Prev.19, 1498-1505 2010
6. Kuo, S. C., et al. Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study. Br. J. Cancer 109, 229-234 (2013
7. Smith, J. S., et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int. J. Cancer 111, 431-439 (2004
8. Caini, S., et al. Sexually transmitted infections and prostate cancer risk: a systematic review and meta-Analysis. Cancer Epidemiol. 38, 329-338 (2014
9. Wotherspoon, A. C., et al. Regression of primary low-grade B cell gastric lymphoma of mucosa-Associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577 (1993
10. Ferreri, A. J., et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J. Clin. Oncol. 23, 5067-5073 (2005
11. Lecuit, M., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350, 239-248 (2004
12. Arthur, J. C., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012
13. Kostic, A. D., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215 (2013
14. Castellarin, M., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012
15. Toprak, N. U., et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12, 782-786 (2006
16. Scanu, T., et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host Microbe 17, 763-774 (2015
17. Hanahan, D., & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011
18. Halazonetis, T. D. Constitutively active DNA damage checkpoint pathways as the driving force for the high frequency of p53 mutations in human cancer. DNA Repair 3, 1057-1062 (2004
19. Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008
20. Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. Genomic instability-An evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220-228 (2010
21. Greaves, M., & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313 (2012
22. Frisan, T. Bacterial genotoxins: the long journey to the nucleus of mammalian cells. Biochim. Biophys. Acta 1858, 567-575 (2016
23. Nougayrede, J. P., et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848-851 (2006
24. Lara-Tejero, M., & Galan, J. E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I like protein. Science 290, 354-357 (2000
25. Brigotti, M., et al. Shiga toxin 1: damage to DNA in vitro. Toxicon 39, 341-348 (2001
26. Weyler, L., et al. Restriction endonucleases from invasive Neisseria gonorrhoeae cause double-strand breaks and distort mitosis in epithelial cells during infection. PLoS ONE 9, e114208 (2014
27. Nipic, D., Podlesek, Z., Budic, M., Crnigoj, M., & Zgur-Bertok, D. Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J. Infect. Dis. 208, 1545-1552 (2013
28. Elsen, S., Collin-Faure, V., Gidrol, X., & Lemercier, C. The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells. Cell. Mol. Life Sci. 70, 4385-4397 (2013
29. Putze, J., et al. Genetic structure and distribution of the colibactin genomic island among members of the family. Infect. Immun. 77, 4696-4703 (2009
30. Balskus, E. P. Colibactin: understanding an elusive gut bacterial genotoxin. Nat. Prod. Rep. 32, 1534-1540 (2015
31. Nowrouzian, F. L., & Oswald, E. Escherichia coli strains with the capacity for long-Term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb. Pathog. 53, 180-182 (2012
32. Nowrouzian, F. L., Wold, A. E., & Adlerberth, I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J. Infect. Dis. 191, 1078-1083 (2005
33. Buc, E., et al. High prevalence of mucosa-Associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 8, e56964 (2013
34. Cuevas-Ramos, G., et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537-11542 (2010
35. Cougnoux, A., et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-Associated secretory phenotype. Gut 63, 1932-1942 (2014
36. Stein, U., et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat. Med. 15, 59-67 (2009
37. Peruzzi, B., & Bottaro, D. P. Targeting the c Met signaling pathway in cancer. Clin. Cancer Res. 12, 3657-3660 (2006
38. Jinadasa, R. N., Bloom, S. E., Weiss, R. S., & Duhamel, G. E. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 157, 1851-1875 (2011
39. Scott, D. A., & Kaper, J. B. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62, 244-251 (1994
40. Boesze-Battaglia, K., et al. Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell. Microbiol. 8, 823-836 (2006
41. Cortes-Bratti, X., Chaves-Olarte, E., Lagergard, T., & Thelestam, M. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 68, 6903-6911 (2000
42. Elwell, C. A., & Dreyfus, L. A. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37, 952-963 (2000
43. Frisan, T., Cortes-Bratti, X., Chaves-Olarte, E., Stenerlow, B., & Thelestam, M. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell. Microbiol. 5, 695-707 (2003
44. Cortes-Bratti, X., Karlsson, C., Lagergard, T., Thelestam, M., & Frisan, T. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276, 5296-5302 (2001
45. Blazkova, H., et al. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J. Cell. Mol. Med. 14, 357-367 (2010
46. Ge, Z., et al. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 9, 2070-2080 (2007
47. Levi, L., Toyooka, T., Patarroyo, M., & Frisan, T. Bacterial genotoxins promote inside-out integrin β1 activation, formation of focal adhesion complexes and cell spreading. PLoS ONE 10, e0124119 (2015
48. Guerra, L., et al. A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS ONE 3, e2254 (2008
49. Guidi, R., et al. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell. Microbiol. 15, 98-113 (2013
50. Parret, A. H., & De Mot, R. Escherichia coli's uropathogenic-specific protein: a bacteriocin promoting infectivity?. Microbiology 148, 1604-1606 (2002
51. Kanamaru, S., et al. Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups. Int. J. Urol. 13, 754-760 (2006
52. Barbieri, J. T., & Sun, J. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152, 79-92 (2004
53. Siddiqui, M. S., Francois, M., Fenech, M. F., & Leifert, W. R. Persistent γH2AX: a promising molecular marker of DNA damage and aging. Mutat. Res. Rev. Mutat. Res. 766, 1-19 (2015
54. Bonner, W. M., et al. γH2AX and cancer. Nat. Rev. Cancer 8, 957-967 (2008
55. Efeyan, A., & Serrano, M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6 1006-1010 2007
56. Liang, Y., Liu, J., & Feng, Z. The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci. 3, 9 (2013
57. Lanjouw, E., et al. 2015 European guideline on the management of Chlamydia trachomatis infections. Int. J. STD AIDS 27, 333-348 (2015
58. Chumduri, C., Gurumurthy, R. K., Zadora, P. K., Mi, Y., & Meyer, T. F. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 13, 746-758 (2013
59. Ferreri, A. J., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl Cancer Inst. 96, 586-594 (2004
60. Siegl, C., Prusty, B. K., Karunakaran, K., Wischhusen, J., & Rudel, T. Tumor suppressor p53 alters host cell metabolism to limit Chlamydia trachomatis infection. Cell Rep. 9, 918-929 (2014
61. Gonzalez, E., et al. Chlamydia infection depends on a functional MDM2-p53 axis. Nat. Commun. 5, 5201 (2014
62. Liberti, M. V., & Locasale, J. W. The Warburg effect: how does it benefit cancer cells?. Trends Biochem. Sci. 41, 211-218 (2016
63. Jennison, A. V., & Verma, N. K. Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiol. Rev. 28, 43-58 (2004
64. Bergounioux, J., et al. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche. Cell Host Microbe 11, 240-252 (2012
65. Hatakeyama, M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4, 688-694 (2004
66. Hartung, M. L., et al. H. pylori-induced DNA strand breaks are introduced by nucleotide excision repair endonucleases and promote NF ?B target gene expression. Cell Rep. 13, 70-79 (2015
67. Toller, I. M., et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc. Natl Acad. Sci. USA 108, 14944-14949 (2011
68. Hanada, K., et al. Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect. Immun. 82, 4182-4189 (2014
69. Blaser, M. J., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55, 2111-2115 (1995
70. Wei, J., et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology 139, 1333-1343 (2010
71. Wei, J., et al. Bacterial CagA protein induces degradation of p53 protein in a p14ARF dependent manner. Gut 64, 1040-1048 (2015
72. Buti, L., et al. Helicobacter pylori cytotoxin-Associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl Acad. Sci. USA 108, 9238-9243 (2011
73. Wei, J., et al. Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc. Natl Acad. Sci. USA 109, E2543-E2550 (2012
74. Unemo, M., & Shafer, W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin. Microbiol. Rev. 27, 587-613 (2014
75. Vielfort, K., et al. Neisseria gonorrhoeae infection causes DNA damage and affects the expression of p21, 27 and p53 in non-Tumor epithelial cells. J. Cell Sci. 126, 339-347 (2013
76. Stavru, F., Archambaud, C., & Cossart, P. Cell biology and immunology of Listeria monocytogenes infections: novel insights. Immunol. Rev. 240, 160-184 (2011
77. Samba-Louaka, A., et al. Listeria monocytogenes dampens the DNA damage response. PLoS Pathog. 10, e1004470 (2014
78. Lam, G. Y., et al. Listeriolysin O suppresses phospholipase C mediated activation of the microbicidal NADPH oxidase to promote Listeria monocytogenes infection. Cell Host Microbe 10, 627-634 (2011
79. Leitao, E., et al. Listeria monocytogenes induces host DNA damage and delays the host cell cycle to promote infection. Cell Cycle 13, 928-940 (2014
80. Li, S. K., & Martin, A. Mismatch repair and colon cancer: mechanisms and therapies explored. Trends Mol. Med. 22, 274-289 (2016
81. Maddocks, O. D., Scanlon, K. M., & Donnenberg, M. S. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. mBio 4, e00152-13 (2013
82. Holmes, A., Mühlen, S., Roe, A. J., & Dean, P. The EspF effector, a bacterial pathogen's Swiss army knife. Infect. Immun. 78, 4445-4453 (2010
83. Kim, J. J., et al. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123, 542-553 (2002
84. Machado, A. M., et al. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin. Cancer Res. 15, 2995-3002 (2009
85. Clements W. M., et al.β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62, 3503-3506 2002
86. Berx, G., Becker, K. F., Hofler, H., & van Roy, F. Mutations of the human E cadherin (CDH1) gene. Hum. Mutat. 12, 226-237 (1998
87. Caputo, R., et al. Helicobacter pylori VacA toxin up regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase 2 dependent mechanism. Clin. Cancer Res. 9, 2015-2021 (2003
88. Tabassam, F. H., Graham, D. Y., & Yamaoka, Y. Helicobacter pylori activate epidermal growth factor receptor-And phosphatidylinositol 3 OH kinase-dependent Akt and glycogen synthase kinase 3β phosphorylation. Cell. Microbiol. 11, 70-82 (2009
89. Nakayama, M., et al. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J. Biol. Chem. 284, 1612-1619 (2009
90. Polk, D. B., & Peek, R. M. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10, 403-414 (2010
91. Sokolova, O., Bozko, P. M., & Naumann, M. Helicobacter pylori suppresses glycogen synthase kinase 3β to promote β-catenin activity. J. Biol. Chem. 283, 29367-29374 (2008
92. Suzuki, M., et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5, 23-34 (2009
93. McCracken, K. W., et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516, 400-404 (2014
94. Bertaux-Skeirik, N., et al. CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation. PLoS Pathog. 11, e1004663 (2015
95. Murata-Kamiya, N., et al. Helicobacter pylori CagA interacts with E cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26, 4617-4626 (2007
96. Kurashima, Y., et al. Deregulation of β-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int. J. Cancer 122, 823-831 (2008
97. Lee, D. G., et al. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK 3 activity. Nat. Commun. 5, 4423 (2014
98. Wroblewski, L. E., et al. Helicobacter pylori targets cancer-Associated apical-junctional constituents in gastroids and gastric epithelial cells. Gut 64, 720-730 (2015
99. Liu, X., Lu, R., Xia, Y., Wu, S., & Sun, J. Eukaryotic signaling pathways targeted by Salmonella effector protein AvrA in intestinal infection in vivo. BMC Microbiol. 10, 326 (2010
100. Ye, Z., Petrof, E. O., Boone, D., Claud, E. C., & Sun, J. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am. J. Pathol. 171, 882-892 (2007
101. Liu, X., Lu, R., Wu, S., & Sun, J. Salmonella regulation of intestinal stem cells through the Wnt/β-catenin pathway. FEBS Lett. 584, 911-916 (2010
102. Lu, R., et al. Consistent activation of the β-catenin pathway by Salmonella type-Three secretion effector protein AvrA in chronically infected intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G1113-G1125 (2012
103. Lu, R., et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis 3, e105 (2014
104. Ricci-Vitiani, L., Pagliuca, A., Palio, E., Zeuner, A., & De Maria, R. Colon cancer stem cells. Gut 57, 538-548 (2008
105. Allen-Vercoe, E., & Jobin, C. Fusobacterium and Enterobacteriaceae: important players for CRC?. Immunol. Lett. 162, 54-61 (2014
106. Han, Y. W., & Wang, X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J. Dental Res. 92, 485-491 (2013
107. Rubinstein, M. R., et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206 (2013
108. Kostic, A. D., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012
109. Sears, C. L., Geis, A. L., & Housseau, F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J. Clin. Invest. 124, 4166-4172 (2014
110. Sears, C. L. The toxins of Bacteroides fragilis. Toxicon 39, 1737-1746 (2001
111. Wu, S., Lim, K. C., Huang, J., Saidi, R. F., & Sears, C. L. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E cadherin. Proc. Natl Acad. Sci. USA 95, 14979-14984 (1998
112. Wu, S., Morin, P. J., Maouyo, D., & Sears, C. L. Bacteroides fragilis enterotoxin induces c Myc expression and cellular proliferation. Gastroenterology 124, 392-400 (2003
113. Wu, S., Rhee, K. J., Zhang, M., Franco, A., & Sears, C. L. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and γ-secretase-dependent E cadherin cleavage. J. Cell Sci. 120, 1944-1952 (2007
114. Lee, I. O., et al. Helicobacter pylori CagA phosphorylation status determines the gp130 activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J. Biol. Chem. 285, 16042-16050 (2010
115. Bronte-Tinkew, D. M., et al. Helicobacter pylori cytotoxin-Associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res. 69, 632-639 (2009
116. Jackson, C. B., et al. Augmented gp130 mediated cytokine signalling accompanies human gastric cancer progression. J. Pathol. 213, 140-151 (2007
117. Laurence, A., et al. Interleukin 2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007
118. Sebkova, L., et al. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL 17)-induced IL 8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect. Immun. 72, 5019-5026 (2004
119. Brandt, S., Kwok, T., Hartig, R., Konig, W., & Backert, S. NF ?B activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA 102, 9300-9305 (2005
120. Mimuro, H., et al. Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol. Cell 10, 745-755 (2002
121. Viala, J., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166-1174 (2004
122. Allison, C. C., Kufer, T. A., Kremmer, E., Kaparakis, M., & Ferrero, R. L. Helicobacter pylori induces MAPK phosphorylation and AP 1 activation via a NOD1 dependent mechanism. J. Immunol. 183, 8099-8109 (2009
123. Shaulian, E., & Karin, M. AP 1 in cell proliferation and survival. Oncogene 20, 2390-2400 (2001
124. Chang, Y. J., et al. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell. Microbiol. 8, 1740-1752 (2006
125. Mimuro, H., et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2, 250-263 (2007
126. Zhao, D., et al. Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J. Med. Microbiol. 59, 259-265 (2010
127. Liu, Z., et al. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J. Cell. Biochem. 113, 1080-1086 (2012
128. Liu, N., et al. Helicobacter pylori promotes VEGF expression via the p38 MAPK-mediated COX 2 PGE2 pathway in MKN45 cells. Mol. Med. Rep. 10, 2123-2129 (2014
129. Hundal, R., & Shaffer, E. A. Gallbladder cancer: epidemiology and outcome. Clin. Epidemiol. 6, 99-109 (2014
130. Crump, J. A., Luby, S. P., & Mintz, E. D. The global burden of typhoid fever. Bull. World Health Organ. 82, 346-353 (2004
131. Nath, G., et al. Association of carcinoma of the gallbladder with typhoid carriage in a typhoid endemic area using nested PCR. J. Infect. Dev. Ctries 2, 302-307 (2008
132. Randi, G., Franceschi, S., & La Vecchia, C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 118, 1591-1602 (2006
133. Kuijl, C., et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT. Nature 450, 725-730 (2007
134. Hannemann, S., Gao, B., & Galan, J. E. Salmonella modulation of host cell gene expression promotes its intracellular growth. PLoS Pathog. 9, e1003668 (2013
135. Jones, R. M., et al. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3, 233-244 (2008
136. Wu, H., Jones, R. M., & Neish, A. S. The Salmonella effector AvrA mediates bacterial intracellular survival during infection in vivo. Cell. Microbiol. 14, 28-39 (2012
137. Du, F., & Galan, J. E. Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog. 5, e1000595 (2009
138. Wu, S., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 (2009
139. Kim, J. M., et al. Mitogen-Activated protein kinase and activator protein 1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis. Eur. J. Immunol. 35, 2648-2657 (2005
140. Wu, S., et al. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin 8 through mitogen-Activated protein kinases and a tyrosine kinase-regulated nuclear factor-?B pathway. Infect. Immun. 72, 5832-5839 (2004
141. Kim, J. M., Lee, J. Y., & Kim, Y. J. Inhibition of apoptosis in Bacteroides fragilis enterotoxin-stimulated intestinal epithelial cells through the induction of c IAP 2. Eur. J. Immunol. 38, 2190-2199 (2008
142. Buchholz, K. R., & Stephens, R. S. The extracellular signal-regulated kinase/mitogen-Activated protein kinase pathway induces the inflammatory factor interleukin 8 following Chlamydia trachomatis infection. Infect. Immun. 75, 5924-5929 (2007
143. Su, H., et al. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279, 9409-9416 (2004
144. Kun, D., Xiang-Lin, C., Ming, Z., & Qi, L. Chlamydia inhibit host cell apoptosis by inducing Bag 1 via the MAPK/ERK survival pathway. Apoptosis 18, 1083-1092 (2013
145. Du, K., et al. Chlamydial antiapoptotic activity involves activation of the Raf/MEK/ERK survival pathway. Curr. Microbiol. 63, 341-346 (2011
146. Rajalingam, K., et al. Mcl 1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS ONE 3, e3102 (2008
147. Cutress, R. I., et al. BAG 1 expression and function in human cancer. Br. J. Cancer 87, 834-839 (2002
148. Sedelnikova, O. A., et al. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat. Res. 704, 152-159 (2010
149. Abdul-Sater, A. A., et al. Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. Biol. Chem. 285, 41637-41645 (2010
150. Goodwin, A. C., et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA 108, 15354-15359 (2011
151. Chaturvedi, R., et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 141, 1696-1708.e2 (2011
152. Huycke, M. M., et al. Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol. Microbiol. 42, 729-740 (2001
153. Huycke, M. M., & Moore, D. R. In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic. Biol. Med. 33, 818-826 (2002
154. Huycke, M. M., Abrams, V., & Moore, D. R. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23, 529-536 (2002
155. Yang, Y., et al. Colon macrophages polarized by commensal bacteria cause colitis and cancer through the bystander effect. Transl Oncol. 6, 596-606 (2013
156. Wang, X., et al. 4 Hydroxy 2 nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142, 543-551.e7 (2012
157. Wang, X., & Huycke, M. M. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132, 551-561 (2007
158. Wang, X., et al. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 68, 9909-9917 (2008
159. Wang, X., Allen, T. D., Yang, Y., Moore, D. R., & Huycke, M. M. Cyclooxygenase 2 generates the endogenous mutagen trans 4 hydroxy 2 nonenal in Enterococcus faecalis-infected macrophages. Cancer Prev. Res. (Phila.) 6, 206-216 (2013
160. Wang, X., Yang, Y., & Huycke, M. M. Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut 64, 459-468 (2015
161. Yoshimoto, S., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101 (2013
162. Balkwill, F., Charles, K. A., & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217 (2005
163. Dapito, D. H., et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012
164. Fox, J. G., et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59, 88-97 (2010
165. Poutahidis, T., et al. Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice. PLoS ONE 8, e73933 (2013
166. Lakritz, J. R., et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 6, 9387-9396 (2015
167. Rao, V. P., et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 66, 7395-7400 (2006
168. Plottel, C. S., & Blaser, M. J. Microbiome and malignancy. Cell Host Microbe 10, 324-335 (2011
169. de Martel, C., Plummer, M., Parsonnet, J., van Doorn, L. J., & Franceschi, S. Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. Br. J. Cancer 100, 194-199 (2009
170. Zhou, D., et al. Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: a meta-Analysis. Eur. J. Gastroenterol. Hepatol. 25, 447-454 (2013
171. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012
172. Gur, C., et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344-355 (2015
173. Melenotte, C., et al. B Cell non-Hodgkin lymphoma linked to Coxiella burnetii. Blood 127, 113-121 (2016
174. Nath, G. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J. Gastroenterol. 16, 5395 (2010
175. Louis, P., Hold, G. L., & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672 (2014
176. Lavin, M. F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26, 7749-7758 (2007
177. Czornak, K., Chughtai, S., & Chrzanowska, K. H. Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair. J. Appl. Genet. 49, 383-396 (2008
178. Ciccia, A., & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204 (2010
179. Chiurillo, M. A. Role of the Wnt/β-catenin pathway in gastric cancer: an in depth literature review. World J. Exp. Med. 5, 84-102 (2015
180. Polakis, P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 4, a008052 (2012
181. Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290 (2007
182. Bollrath, J., et al. gp130 mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-Associated tumorigenesis. Cancer Cell 15, 91-102 (2009
183. Yu, H., Pardoll, D., & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9, 798-809 (2009
184. Karin, M. Nuclear factor-?B in cancer development and progression. Nature 441, 431-436 (2006
185. Watanabe, T., Tada, M., Nagai, H., Sasaki, S., & Nakao, M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115, 642-648 (1998
186. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49 347-353 (2001
187. Cheung, T. K., & Wong, B. C. Treatment of Helicobacter pylori and prevention of gastric cancer. J. Dig. Dis. 9, 8-13 (2008
188. Xiao, M., Wang, Y., & Gao, Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-Analysis. PLoS ONE 8, e75559 (2013
189. Raderer, M., et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 55, 16-19 (1998
190. Nagaraja, V., & Eslick, G. D. Systematic review with meta-Analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment. Pharmacol. Ther. 39, 745-750 (2014
191. Lu, R., et al. Chronic effects of a Salmonella type III secretion effector protein AvrA in vivo. PLoS ONE 5, e10505 (2010
192. DeStefano Shields, C. E., et al. Reduction of murine colon tumorigenesis driven by enterotoxigenic Bacteroides fragilis using cefoxitin treatment. J. Infect. Dis. 214, 122-129 (2016
193. Boleij, A., et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208-215 (2015
194. Boleij, A., van Gelder, M. M., Swinkels, D. W., & Tjalsma, H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-Analysis. Clin. Infect. Dis. 53, 870-878 (2011
195. Ahn, J., Segers, S., & Hayes, R. B. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 33, 1055-1058 (2012
196. Chen, Y., & Wei, J. Identification of pathogen signatures in prostate cancer using RNA-seq. PLoS ONE 10, e0128955 (2015
197. Fassi Fehri, L., et al. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int. J. Med. Microbiol. 301, 69-78 (2011
198. Olsson, J., et al. Chronic prostatic infection and inflammation by Propionibacterium acnes in a rat prostate infection model. PLoS ONE 7, e51434 (2012
199. Shinohara, D. B., et al. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 73, 1007-1015 (2013
200. Idahl, A., et al. Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect. Dis. Obstet. Gynecol. 2011, 824627 (2011
201. Barykova, Y. A., et al. Association of Mycoplasma hominis infection with prostate cancer. Oncotarget 2, 289-297 (2011
202. Wotherspoon, A. C., Ortiz-Hidalgo, C., Falzon, M. R., & Isaacson, P. G. Helicobacter pylori-Associated gastritis and primary B cell gastric lymphoma. Lancet 338, 1175-1176 (1991
203. Cavanna, L., Pagani, R., Seghini, P., Zangrandi, A., & Paties, C. High grade B cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J. Surg. Oncol. 6, 35 (2008
204. Ferreri, A. J. M., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl Cancer Inst. 96, 586-594 (2004
205. Goodlad, J. R., et al. Primary cutaneous B cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am. J. Surg. Pathol. 24, 1279-1285 (2000
206. Roggero, E., et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B cell lymphoma of the skin. Hum. Pathol. 31, 263-268 (2000
207. Gillen, C. D., Coddington, R., Monteith, P. G., & Taylor, R. H. Extraintestinal lymphoma in association with Whipple's disease. Gut 34, 1627-1629 (1993
208. Cadenas, F., et al. Persistent leucocytosis as initial manifestation of Whipple's disease and development of gastric cancer in the follow up. Rev. Esp. Enferm. Dig. 91, 785-788 (in Spanish) (1999
209. Mohm, J., Naumann, R., Schuler, U., & Ehninger, G. Abdominal lymphomas, convulsive seizure and coma: a case of successfully treated, advanced Whipple's disease with cerebral involvement. Eur. J. Gastroenterol. Hepatol. 10, 893-895 (1998
210. Gao, S., et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect. Agent. Cancer 11, 3 (2016